Sign in
BIOCQ Stock Price, Chart, Stats & News
Biocept, Inc.
Save
Biocept, Inc. (BIOCQ) does not currently pay a dividend.
–
Market cap
–
Current P/E
–
Forward P/E
BIOCQ chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | -9.99% |
Operating margin | -123.69% |
Pretax margin | -124.57% |
Net margin | -124.09% |
Effective tax rate | 0.39% |
ROA | -103.93% |
ROE | -138.49% |
D/E | 1.37x |
Interest coverage ratio | -101.21x |
BIOCQ valuation
P/E | – |
P/S | 0.00x |
P/B | 0.00x |
P/CF | -0.00x |
P/FCF | -0.00x |
P/OCF | -0.00x |
PEG | -0.00x |
EV multiple | -0.03x |
About
Biocept, Inc., established in 1997 and based in San Diego, California, was a molecular oncology diagnostics firm. Its primary business involved the development and commercialization of exclusive clinical laboratory assays within the United States. These advanced tests were engineered to detect elusive tumor cells and cell-free tumor DNA (ctDNA) from both blood and cerebrospinal fluid (CSF) samples.
Similar securities
Based on sector and market capitalization
Report issue